FDA环氧乙烷灭菌设施 III 类设备变更的过渡性执法政策_中英文版
VIP专享
Contains Nonbinding Recommendations
Transitional Enforcement Policy for
Ethylene Oxide Sterilization Facility
Changes for Class III Devices
Guidance for Industry and
Food and Drug Administration Staff
Document issued on November 26, 2024.
For questions about this document regarding CDRH-regulated devices, contact CDRH-ETO-
SiteChange@fda.hhs.gov.
For questions about this document regarding CBER-regulated devices, contact
ocod@fda.hhs.gov.
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Devices and Radiological Health
Center for Biologics Evaluation and Research
Contains Nonbinding Recommendations
Preface
Public Comment
You may submit electronic comments and suggestions at any time for Agency consideration to
https://www.regulations.gov. Submit written comments to the Dockets Management Staff, Food
and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852-
1740. Identify all comments with the docket number FDA-2024-D-2274. Comments may not be
acted upon by the Agency until the document is next revised or updated.
Additional Copies
CDRH
Additional copies are available from the Internet. You may also send an email request to CDRH-
Guidance@fda.hhs.gov to receive a copy of the guidance. Please include the document number
GUI00007027 and complete title of the guidance in the request.
CBER
Additional copies of this guidance are available from the Office of Communication, Outreach
and Development (OCOD), 10903 New Hampshire Ave., Bldg. 71, Rm. 3128, Silver Spring,
MD 20993-0002, or by calling 1-800-835-4709 or 240-402-8010, or email ocod@fda.hhs.gov, or
from the Internet at https://www.fda.gov/vaccines-blood-biologics/guidance-compliance-
regulatory-information-biologics.
For questions on the content of this guidance, contact OCOD at the phone numbers or email
address listed above.
摘要:
展开>>
收起<<
ContainsNonbindingRecommendationsTransitionalEnforcementPolicyforEthyleneOxideSterilizationFacilityChangesforClassIIIDevicesGuidanceforIndustryandFoodandDrugAdministrationStaffDocumentissuedonNovember26,2024.ForquestionsaboutthisdocumentregardingCDRH-regulateddevices,contactCDRH-ETO-SiteChange@fda.h...
声明:如果您的权利被侵害,请联系我们的进行举报。
相关推荐
-
ISO 14155-2020 医疗器械临床实验管理规范(中文版)VIP免费
2025-09-17 314 -
ISO TS 10974-2018 评估有植入式医疗设备的患者进行磁共振成像的安全性VIP免费
2025-10-30 165 -
ISO TS 10974-2018 评估有植入式医疗设备的患者进行磁共振成像的安全性(中文版)
2025-10-30 172 -
ISO TS 10974-2018 评估有植入式医疗设备的患者进行磁共振成像的安全性_中英文版VIP专享
2025-10-30 104 -
ISO 10993-1-2018 医疗器械生物学评价 第1部分:风险管理过程中的评价与试验_中英文对照VIP专享
2025-11-03 123 -
ISO 14155-2026 人体医疗器械临床试验--良好临床实践VIP免费
2026-04-15 114 -
ISO IEC 17020 2026 Conformity assessment— Requirements for bodies performing inspectionVIP免费
2026-05-14 104 -
ISO 19011-2026-管理体系审核指南VIP免费
2026-06-03 90 -
ISO 19011-2026-管理体系审核指南(中文)VIP免费
2026-06-04 179 -
ISO FDIS 9001_2026质量管理体系要求中英文版VIP免费
2026-07-02 123
作者:薛定谔的龙猫
分类:专业资料
价格:80质量币
属性:42 页
大小:1.13MB
格式:PDF
时间:2025-11-12

